Henry Sonneborn - Concepedia

Author

Henry Sonneborn

Harvard University

Also Known As

H Sonneborn, H.L. Sonneborn, Henry L. Sonneborn, Henry Sonneborn

Publications

409

Citations

H-Index

Concepts

All Affiliations

Harvard University Deaconess Hospital

About

Henry Sonneborn is an author at Harvard University specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	170
2	Pharmacology	6	6	170
3	Health Sciences	1	1	23
4	Pathology	1	1	24
5	Surgical Oncology	1	1	26

Henry Sonneborn

Publications

373

Citations

H-Index

Page 1

	Year	Citations
Thalidomide and rituximab in Waldenstrom macroglobulinemia Steven P. Treon, Jacob D. Soumerai, Andrew R. Branagan, Blood	2008	143
Constant infusion schedule for adriamycin: a phase I-II clinical trial of a 30-day schedule by ambulatory pump delivery system. Jacob J. Lokich, Albert Bothe, T Zipoli, Journal of Clinical Oncology Therapeutic Drug MonitoringScalp HairPharmacologyConstant Infusion ScheduleTopical Drug	1983	70
Combined paclitaxel, cisplatin, and etoposide for patients with previously untreated esophageal and gastroesophageal carcinomas Jacob J. Lokich, Henry Sonneborn, Norwood Anderson, Cancer	1999	44
Cancer chemotherapy via ambulatory infusion pump Jacob J. Lokich, J. Perri, Albert Bothe, American Journal of Clinical Oncology Surgical OncologyGastrointestinal OncologyMedicineConstant Intravenous InfusionPharmacology	1983	26
Doxorubicin/vinblastine and doxorubicin/cyclophosphamide combination chemotherapy by continuous infusion Jacob J. Lokich, T Zipoli, Cherie Moore, Cancer Dox/ctx AdmixtureMedicinePharmacologyPathologyInfusion Schedule	1986	24
Phase I study of continuous venous infusion of floxuridine (5-FUDR) chemotherapy. J Lokich, Henry Sonneborn, S. Paul, PubMed PharmacotherapyMetronomic ChemotherapyOncologyMetronomic TherapyHematology	1983	23
5-fluorouracil and methotrexate administered simultaneously as a continuous infusion. A phase I study Jacob J. Lokich, Donald A. Phillips, Robert C. Green, Cancer Drug SafetyTranslational MedicineOncologyMtx AdministrationMedicine	1985	16
Phase II Study of Aclarubicin in Acute Myeloblastic Leukemia Delvyn C. Case, Thomas J. Ervin, Marjorie A. Boyd, American Journal of Clinical Oncology	1987	16
Paclitaxel, cisplatin and etoposide combination chemotherapy: a comparison of dose intensity in two multifractionated dose schemas Jacob J. Lokich, N. Anderson, Cherie Moore, European Journal of Cancer MedicineCancer ManagementPharmacologyEtoposide Combination ChemotherapyDose Intensity	1998	11

Page 1